Virus injection targets pancreatic tumors in new trial
NCT ID NCT06693986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a specially modified virus that is injected directly into pancreatic tumors during an endoscopic procedure. The goal is to find the safest dose that can control the disease without causing severe side effects. The trial involves 18 adults with pancreatic adenocarcinoma that has not spread beyond the pancreas and nearby lymph nodes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF PANCREAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Masonic Cancer Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.